Patent classifications
A61N5/0603
TREATMENT METHOD FOR LUMINAL ORGAN
A method of cholecystitis treatment according to an aspect of the present disclosure comprises a step A including contacting inner walls of a gallbladder to each other by constricting the gallbladder and a step B including maintaining the inner walls of the gallbladder contacting each other.
ELECTROMAGNETIC RADIATION AND MULTI-PHASE ORAL COMPOSITIONS FOR ORAL CARE
A kit includes a multi-phase oral composition for whitening teeth and an electromagnetic radiation source. The multi-phase oral composition for whitening teeth includes from about 0.002% to about 30%, by weight of the multi-phase oral composition, of a discontinuous aqueous phase having a bleaching agent, where a concentration of the bleaching agent is up to 10%, by weight of the multi-phase oral composition, and at least about 50%, by weight of the multi-phase oral composition, of a continuous hydrophobic phase of petrolatum. The electromagnetic radiation source is capable of directing electromagnetic radiation with one or more wavelength in the range from about 200 nm to about 1700 nm toward at least one tooth. The electromagnetic radiation source emits electromagnetic radiation in a range from about 100 mW/cm.sup.2 to about 250 mW/cm.sup.2.
PHOTOBIOMODULATION SYSTEM AND METHOD FOR IMPROVED IMMUNITY AND TREATMENT OF RESPIRATORY TRACT INFECTIONS
A self-administrable system for improved immunity and treatment of respiratory tract infections in a subject, said system comprising: a configured irradiation unit for delivery of light energy into at least one portion of an in-vivo target selected from the group consisting of the thymus gland, sternal bone marrow and lungs.
Prevenative dental hard tissue laser treatment systems and methods
In one aspect, embodiments relate to a system for preventative dental laser treatment that ensures even irradiation of a laser beam. The system includes, a laser arrangement configured to generate the laser beam. The laser beam has one or more of a super-Gaussian energy profile and a transverse ring mode. The system also includes a focus optic. The focus optic is configured to converge the laser beam with a numerical aperture of 0.1 or less to a focal region. The system also includes a hand piece configured to direct the laser beam at a surface of a dental hard tissue. The system additionally includes a controller. The controller is configured to control one or more parameters of the laser source, such that a portion of the surface of the dental hard tissue is heated to a temperature in a range between 400° Celsius and 1300° Celsius.
TREATMENT APPARATUS AND TREATMENT METHOD
A treatment apparatus and a treatment method capable of minimally invasively specifying a lesion extent and checking progress of treatment while performing the treatment for destroying tumor cells. The treatment apparatus that detects and destroys a tumor cell by irradiating an antibody-photosensitive substance adsorbed on a tumor cell membrane with excitation light includes: an elongated tubular shaft having optical transparency; a light irradiation unit configured to emit the excitation light of the antibody-photosensitive substance from an inside of the shaft in a side direction perpendicular to an axial direction of the shaft; and a side direction fluorescence detection unit configured to detect, from the side direction perpendicular to the axial direction of the shaft, fluorescence emitted by the excited antibody-photosensitive substance, and movable in the axial direction with respect to the shaft.
Light treatment system and balloon catheter
A light treatment system includes: a probe configured to be inserted into a bladder, the probe including an optical fiber configured to propagate light, and a light emitter that is provided at a distal end of the optical fiber, the light emitter being configured to emit the light; and a balloon catheter into which the probe is inserted, the balloon catheter being configured to be inserted into the bladder, the balloon catheter including a distal end portion that is to be dilated in the bladder, a wall configured to divide inside of the distal end portion into two regions, and a reflector configured to reflect the light emitted by the light emitter, the reflector being provided on a surface of the wall, the surface facing a region of the two regions, the region being where the light emitter is positioned.
TREATMENT OF MUCOSITIS USING PHOTOBIOMODULATION
A method for treating an oral cavity malady of a patient, comprising: applying a spot of a laser beam to a target area around the oral cavity, said laser beam having a wavelength of about 800 to 840 nm and a power of between 1000 and 4000 mW, and wherein said spot has a spot size of about 1 to about 10 mm; and moving said spot on said target area for a treatment time sufficient to deliver a dose of about 0.5 to about 30 J/cm.sup.2 to said target area.
System and method for automated personalized brain modulation with photobiomodulation
A novel photobiomodulation (PBM) system and method that comprehensively directs therapeutic light energy into the brain from a combination of transcranial (through the skull) and intranasal (via the nasal channels) locations. In a preferred embodiment, the PBM device works in combination with a diagnostic tool to provide enhanced treatment of abnormal brain function intelligently, automatically, and unrestricted by geographical distances.
METHODS AND DEVICES TO TREAT NASAL AIRWAYS
Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.
AN INGESTIBLE THERAPEUTIC DEVICE FOR THE TREATMENT OF GASTRITIS
An ingestible gastrointestinal phototherapy device has a spherocylindrical body of non-digestible material having a cylindrical midsection and transparent light portals at ends thereof. The cylindrical midsection has control circuitry and a power source therein and each light portal is transparent and comprises an array of bioactive light source elements therein emitting bioactive light therefrom and being operably coupled to the control circuitry and power source.